(BBDC) Barings BDC - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US06759L1035
Stock: Senior Loans, Unitranche Debt, Subordinated Debt, Equity Co-Investments
Total Rating 34
Risk 57
Buy Signal -1.17
| Risk 5d forecast | |
|---|---|
| Volatility | 33.0% |
| Relative Tail Risk | -0.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.63 |
| Alpha | -21.86 |
| Character TTM | |
|---|---|
| Beta | 0.547 |
| Beta Downside | 1.027 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.45% |
| CAGR/Max DD | 0.37 |
EPS (Earnings per Share)
Revenue
Description: BBDC Barings BDC February 27, 2026
Barings BDC, Inc. (NYSE: BBDC) is an externally managed business development company that focuses on senior secured and mezzanine financing for U.S. middle-market companies. Its portfolio targets firms with EBITDA of $10 million–$75 million and revenues up to $200 million, spanning manufacturing, business services, technology, logistics and consumer sectors.
As of the most recent quarter (Q4 2025), BBDC reported a net asset value (NAV) of $13.42 per share and a dividend yield of roughly 9.1%, supported by a 93% weighted-average credit rating (B-) across its loan portfolio. The fund’s assets under management have grown to $1.6 billion, with 68% of investments in senior secured loans and the remainder in unitranche and equity co-investments.
Demand for private credit in the lower-middle market remains strong, driven by continued private-equity sponsor activity and a modestly tightening U.S. credit cycle that favors higher-yield, secured financing. Monitoring interest-rate trends and corporate earnings in the targeted EBITDA range will be key to assessing BBDC’s future performance.
For a deeper dive into the valuation and risk profile, you might explore additional data on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 28.11b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -11.17 > 1.0 |
| NWC/Revenue: 9.55% < 20% (prev 49.78%; Δ -40.23% < -1%) |
| CFO/TA 0.00 > 3% & CFO 534.0k > Net Income 28.11b |
| Net Debt (1.36b) to EBITDA (121.6m): 11.21 < 3 |
| Current Ratio: 2.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.2m) vs 12m ago -0.35% < -2% |
| Gross Margin: 71.77% > 18% (prev 0.62%; Δ 7115 % > 0.5%) |
| Asset Turnover: 8.60% > 50% (prev 7.82%; Δ 0.77% > 0%) |
| Interest Coverage Ratio: 1.75 > 6 (EBITDA TTM 121.6m / Interest Expense TTM 85.1m) |
Altman Z'' -0.86
| A: 0.01 (Total Current Assets 41.4m - Total Current Liabilities 19.5m) / Total Assets 2.64b |
| B: -0.27 (Retained Earnings -702.3m / Total Assets 2.64b) |
| C: 0.06 (EBIT TTM 148.8m / Avg Total Assets 2.67b) |
| D: -0.41 (Book Value of Equity -598.3m / Total Liabilities 1.48b) |
| Altman-Z'' Score: -0.86 = CCC |
Beneish M
| DSRI: 0.68 (Receivables 41.4m/56.3m, Revenue 229.2m/210.9m) |
| GMI: 0.86 (GM 71.77% / 61.65%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.09 (Revenue 229.2m / 210.9m) |
| TATA: 10.66 (NI 28.11b - CFO 534.0k) / TA 2.64b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of BBDC shares?
As of March 01, 2026, the stock is trading at USD 8.44 with a total of 939,718 shares traded.
Over the past week, the price has changed by -8.06%, over one month by -7.35%, over three months by -4.93% and over the past year by -11.29%.
Over the past week, the price has changed by -8.06%, over one month by -7.35%, over three months by -4.93% and over the past year by -11.29%.
Is BBDC a buy, sell or hold?
Barings BDC has received a consensus analysts rating of 4.40.
Therefore, it is recommended to buy BBDC.
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BBDC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.7 | 14.9% |
| Analysts Target Price | 9.7 | 14.9% |
BBDC Fundamental Data Overview February 23, 2026
P/E Trailing = 9.5625
P/E Forward = 8.4175
P/S = 3.4249
P/B = 0.8192
Revenue TTM = 229.2m USD
EBIT TTM = 148.8m USD
EBITDA TTM = 121.6m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.36b USD (from netDebt column, last quarter)
Enterprise Value = 2.33b USD (965.4m + Debt 1.43b - CCE 66.8m)
Interest Coverage Ratio = 1.75 (Ebit TTM 148.8m / Interest Expense TTM 85.1m)
EV/FCF = 1000.0x (Enterprise Value 2.33b / FCF TTM 534.0k)
FCF Yield = 0.02% (FCF TTM 534.0k / Enterprise Value 2.33b)
FCF Margin = 0.23% (FCF TTM 534.0k / Revenue TTM 229.2m)
Net Margin = 12.3k% (Net Income TTM 28.11b / Revenue TTM 229.2m)
Gross Margin = 71.77% ((Revenue TTM 229.2m - Cost of Revenue TTM 64.7m) / Revenue TTM)
Gross Margin QoQ = 85.59% (prev 80.22%)
Tobins Q-Ratio = 0.88 (Enterprise Value 2.33b / Total Assets 2.64b)
Interest Expense / Debt = 1.48% (Interest Expense 21.2m / Debt 1.43b)
Taxrate = 4.62% (1.23m / 26.6m)
NOPAT = 142.0m (EBIT 148.8m * (1 - 4.62%))
Current Ratio = 2.12 (Total Current Assets 41.4m / Total Current Liabilities 19.5m)
Debt / Equity = 1.23 (Debt 1.43b / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 11.21 (Net Debt 1.36b / EBITDA 121.6m)
Debt / FCF = 2553 (out of range, set to none) (Net Debt 1.36b / FCF TTM 534.0k)
Total Stockholder Equity = 1.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 1054 % (out of range, set to none)
RoE = 2396 % (out of range, set to none) (Net Income TTM 28.11b / Total Stockholder Equity 1.17b)
RoCE = 5.69% (EBIT 148.8m / Capital Employed (Total Assets 2.64b - Current Liab 19.5m))
RoIC = 5.17% (NOPAT 142.0m / Invested Capital 2.74b)
WACC = 4.04% (E(965.4m)/V(2.40b) * Re(7.93%) + D(1.43b)/V(2.40b) * Rd(1.48%) * (1-Tc(0.05)))
Discount Rate = 7.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.57%
[DCF] Terminal Value 80.82% ; FCFF base≈121.0m ; Y1≈79.5m ; Y5≈36.3m
[DCF] Fair Price = N/A (negative equity: EV 1.16b - Net Debt 1.36b = -208.3m; debt exceeds intrinsic value)
EPS Correlation: 14.94 | EPS CAGR: 4.37% | SUE: 0.20 | # QB: 0
Revenue Correlation: -7.73 | Revenue CAGR: 7.53% | SUE: -0.33 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.25 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=+2 | Analysts=5
EPS current Year (2026-12-31): EPS=0.97 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=-1 | Growth EPS=-13.0% | Growth Revenue=-8.9%
EPS next Year (2027-12-31): EPS=0.89 | Chg7d=+0.015 | Chg30d=+0.015 | Revisions Net=-2 | Growth EPS=-8.6% | Growth Revenue=-6.4%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.5% (Discount Rate 7.9% - Earnings Yield 10.5%)
[Growth] Growth Spread = -0.8% (Analyst -3.3% - Implied -2.5%)
P/E Forward = 8.4175
P/S = 3.4249
P/B = 0.8192
Revenue TTM = 229.2m USD
EBIT TTM = 148.8m USD
EBITDA TTM = 121.6m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.36b USD (from netDebt column, last quarter)
Enterprise Value = 2.33b USD (965.4m + Debt 1.43b - CCE 66.8m)
Interest Coverage Ratio = 1.75 (Ebit TTM 148.8m / Interest Expense TTM 85.1m)
EV/FCF = 1000.0x (Enterprise Value 2.33b / FCF TTM 534.0k)
FCF Yield = 0.02% (FCF TTM 534.0k / Enterprise Value 2.33b)
FCF Margin = 0.23% (FCF TTM 534.0k / Revenue TTM 229.2m)
Net Margin = 12.3k% (Net Income TTM 28.11b / Revenue TTM 229.2m)
Gross Margin = 71.77% ((Revenue TTM 229.2m - Cost of Revenue TTM 64.7m) / Revenue TTM)
Gross Margin QoQ = 85.59% (prev 80.22%)
Tobins Q-Ratio = 0.88 (Enterprise Value 2.33b / Total Assets 2.64b)
Interest Expense / Debt = 1.48% (Interest Expense 21.2m / Debt 1.43b)
Taxrate = 4.62% (1.23m / 26.6m)
NOPAT = 142.0m (EBIT 148.8m * (1 - 4.62%))
Current Ratio = 2.12 (Total Current Assets 41.4m / Total Current Liabilities 19.5m)
Debt / Equity = 1.23 (Debt 1.43b / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 11.21 (Net Debt 1.36b / EBITDA 121.6m)
Debt / FCF = 2553 (out of range, set to none) (Net Debt 1.36b / FCF TTM 534.0k)
Total Stockholder Equity = 1.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 1054 % (out of range, set to none)
RoE = 2396 % (out of range, set to none) (Net Income TTM 28.11b / Total Stockholder Equity 1.17b)
RoCE = 5.69% (EBIT 148.8m / Capital Employed (Total Assets 2.64b - Current Liab 19.5m))
RoIC = 5.17% (NOPAT 142.0m / Invested Capital 2.74b)
WACC = 4.04% (E(965.4m)/V(2.40b) * Re(7.93%) + D(1.43b)/V(2.40b) * Rd(1.48%) * (1-Tc(0.05)))
Discount Rate = 7.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.57%
[DCF] Terminal Value 80.82% ; FCFF base≈121.0m ; Y1≈79.5m ; Y5≈36.3m
[DCF] Fair Price = N/A (negative equity: EV 1.16b - Net Debt 1.36b = -208.3m; debt exceeds intrinsic value)
EPS Correlation: 14.94 | EPS CAGR: 4.37% | SUE: 0.20 | # QB: 0
Revenue Correlation: -7.73 | Revenue CAGR: 7.53% | SUE: -0.33 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.25 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=+2 | Analysts=5
EPS current Year (2026-12-31): EPS=0.97 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=-1 | Growth EPS=-13.0% | Growth Revenue=-8.9%
EPS next Year (2027-12-31): EPS=0.89 | Chg7d=+0.015 | Chg30d=+0.015 | Revisions Net=-2 | Growth EPS=-8.6% | Growth Revenue=-6.4%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.5% (Discount Rate 7.9% - Earnings Yield 10.5%)
[Growth] Growth Spread = -0.8% (Analyst -3.3% - Implied -2.5%)